Screening compound: InChI=1S/C21H14F2N2OS/c22-15-11-9-14(10-12-15)13-27-21-24-18-7-3-1-5-16(18)20(26)25(21)19-8-4-2-6-17(19)23/h1-12H,13H2

Screening compound: InChI=1S/C21H14F2N2OS/c22-15-11-9-14(10-12-15)13-27-21-24-18-7-3-1-5-16(18)20(26)25(21)19-8-4-2-6-17(19)23/h1-12H,13H2
Screening compound: InChI=1S/C21H14F2N2OS/c22-15-11-9-14(10-12-15)13-27-21-24-18-7-3-1-5-16(18)20(26)25(21)19-8-4-2-6-17(19)23/h1-12H,13H2 alternative view

Chemical Structure Depiction of ChemDiv screening compound
InChI=1S/C21H14F2N2OS/c22-15-11-9-14(10-12-15)13-27-21-24-18-7-3-1-5-16(18)20(26)25(21)19-8-4-2-6-17(19)23/h1-12H,13H2

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

V007-2283

Molecular Formula

C21H14F2N2OS (C21 H14 F2 N2 OS)

Compound Name

3-(2-fluorophenyl)-2-{[(4-fluorophenyl)methyl]sulfanyl}-3,4-dihydroquinazolin-4-one

IUPAC name

3-(2-fluorophenyl)-2-{[(4-fluorophenyl)methyl]sulfanyl}-34-dihydroquinazolin-4-one

SMILES

O=C1N(c(cccc2)c2F)C(SCc(cc2)ccc2F)=Nc2c1cccc2

InChI

InChI=1S/C21H14F2N2OS/c22-15-11-9-14(10-12-15)13-27-21-24-18-7-3-1-5-16(18)20(26)25(21)19-8-4-2-6-17(19)23/h1-12H,13H2

InChI Key

XZIGUNSAJAUGOL-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD04481902

InChI=1S/C21H14F2N2OS/c22-15-11-9-14(10-12-15)13-27-21-24-18-7-3-1-5-16(18)20(26)25(21)19-8-4-2-6-17(19)23/h1-12H,13H2 in Drug Discovery

Included in Screening Libraries

Allosteric Kinases Inhibitors Library (23117 compounds)

PI3K-Targeted Library (17255 compounds)

Serine Proteases Inhibitors Library (32732 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Female
  • Congenital
  • Skin
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Male
  • Female
  • Hemic and lymphatic
  • Skin
  • Infections
  • Cancer
  • Musculoskeletal
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Cardiovascular
  • Skin
  • Metabolic
  • Immune system
Targets:
  • Kinases
  • Kinases
  • Proteases

References: we are preparing a list of scientific research reports with InChI=1S/C21H14F2N2OS/c22-15-11-9-14(10-12-15)13-27-21-24-18-7-3-1-5-16(18)20(26)25(21)19-8-4-2-6-17(19)23/h1-12H,13H2 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound InChI=1S/C21H14F2N2OS/c22-15-11-9-14(10-12-15)13-27-21-24-18-7-3-1-5-16(18)20(26)25(21)19-8-4-2-6-17(19)23/h1-12H,13H2?
Check Price and Availability of InChI=1S/C21H14F2N2OS/c22-15-11-9-14(10-12-15)13-27-21-24-18-7-3-1-5-16(18)20(26)25(21)19-8-4-2-6-17(19)23/h1-12H,13H2, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of InChI=1S/C21H14F2N2OS/c22-15-11-9-14(10-12-15)13-27-21-24-18-7-3-1-5-16(18)20(26)25(21)19-8-4-2-6-17(19)23/h1-12H,13H2 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for InChI=1S/C21H14F2N2OS/c22-15-11-9-14(10-12-15)13-27-21-24-18-7-3-1-5-16(18)20(26)25(21)19-8-4-2-6-17(19)23/h1-12H,13H2
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for InChI=1S/C21H14F2N2OS/c22-15-11-9-14(10-12-15)13-27-21-24-18-7-3-1-5-16(18)20(26)25(21)19-8-4-2-6-17(19)23/h1-12H,13H2
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of InChI=1S/C21H14F2N2OS/c22-15-11-9-14(10-12-15)13-27-21-24-18-7-3-1-5-16(18)20(26)25(21)19-8-4-2-6-17(19)23/h1-12H,13H2 available by request